Patents by Inventor Cristina Sanchez Garcia

Cristina Sanchez Garcia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prognostic method and kits useful in said method
    Patent number: 10753935
    Abstract: The invention generally relates to diagnostic, prognostic, and monitoring methods and assays for breast cancer and kits that may be used in such methods. More particularly, the invention relates to a method of prognosis of a patient afflicted with breast cancer, including determining the level of HER2/CB2 heteromer expression in a biological sample obtained from the patient.
    Type: Grant
    Filed: July 6, 2018
    Date of Patent: August 25, 2020
    Assignee: Zelda Therapeutics Operations Pty Ltd.
    Inventors: Cristina Sánchez Garcia, Sandra Blasco Benito, Eduardo Pérez Gómez
  • Prognostic Method and Kits Useful in Said Method
    Publication number: 20180313840
    Abstract: The invention generally relates to diagnostic, prognostic, and monitoring methods and assays for breast cancer and kits that may be used in such methods. More particularly, the invention relates to a method of prognosis of a patient afflicted with breast cancer, including determining the level of HER2/CB2 heteromer expression in a biological sample obtained from the patient.
    Type: Application
    Filed: July 6, 2018
    Publication date: November 1, 2018
    Inventors: Cristina Sánchez Garcia, Sandra Blasco Benito, Eduardo Pérez Gómez
  • Therapy with cannabinoid compounds for the treatment of brain tumors
    Publication number: 20040039048
    Abstract: The therapy with cannabinois in the treatment of cerebral tumors involves (intracranial or systematic) administration of (natural of synthetic) cannabinoids to (human or non-human) mammals having cerebral tumors. Activation of the specific receptors of the cannabinoids leads to selective death of the transformed cells. Regression or eradication of the cerebral tumors is achieved without any significant side-effects.
    Type: Application
    Filed: August 25, 2003
    Publication date: February 26, 2004
    Inventors: Manuel Guzman Pastor, Cristina Sanchez Garcia, Ismael Galve Roperh